Skip to main content
    A

    AngioDynamics Inc (ANGO)

    Official site

    HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ

    $11.49
    -0.29 (-2.46%)

    Market Cap: $495.40M

    Last updated: Nov 17, 2026 at 4:15 PM ET

    AngioDynamics Inc (ANGO) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    AngioDynamics (ANGO) has a market cap of $495.40M and an enterprise value of $461.43M. It kept -10.12% of revenue as net income over the last 12 months.

    Total Valuation

    Enterprise value is 6.86% below the market cap, as cash exceeds debt.

    Market Cap$495.40M
    Enterprise Value$461.43M
    Latest price (Nov 17, 2026)$11.49

    Key Dates

    The next earnings report is expected on Jan 4, 2027, covering the quarter ending Nov 30, 2026.

    Next Earnings DateJan 4, 2027 (expected)
    Last Earnings DateOct 8, 2026
    Fiscal Year EndMay

    Share Statistics

    The share count grew 1.79% a year over 3 years.

    Shares Outstanding42.02M
    Shares Change (YoY)+2.06%
    Share Count Growth (3Y CAGR)+1.79%

    Valuation Ratios

    Sales and book value multiples are 1.5x and 2.9x. Its year-end P/S ranged from 0.9x to 3.5x from 2016 to 2025.

    P/S Ratio1.5x
    Forward P/S1.5x
    P/B Ratio2.9x
    P/TBV Ratio4.7x
    P/OCF Ratio134.9x

    Valuation history and multiples

    Price Statistics

    The stock is down 5.12% over 52 weeks and trades 13.48% below its 50-day average.

    Beta (1Y)1.05
    52-Week Change-5.12%
    1-Month Change+0.88%
    3-Month Change-28.50%
    6-Month Change+0.44%
    5-Year Change-58.08%
    10-Year Change-24.78%
    Total Return (1Y)-5.12%
    Total Return (3Y CAGR)+18.99%
    Total Return (5Y CAGR)-16.83%
    Return vs SPY (1Y)-14.84%
    Max Drawdown (1Y)-32.42%
    Max Drawdown (3Y)-35.32%
    Sharpe Ratio (1Y)-0.07
    Correlation with SPY (1Y)0.29
    50-Day Average$13.28
    200-Day Average$12.57
    52-Week Range$9.39 to $16.29
    RSI (14 Days)38.7
    Average Volume (20 Days)528.57K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 2.40x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio2.40x
    Quick Ratio1.48x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -20.09% over the last 12 months, against a 5-year average of -29.97%.

    Return on Equity (ROE)-20.09%
    Return on Assets (ROA)-13.61%
    Return on Capital Employed (ROCE)-17.76%
    ROE (5Y Average)-29.97%
    ROA (5Y Average)-19.71%
    ROIC (5Y Average)-28.90%
    Asset Turnover1.28x
    Inventory Turnover2.69x
    Receivables Turnover6.98x
    Cash Conversion Cycle115 days

    Scores

    ANGO has an Altman Z-Score of 2.29, in the grey zone from 1.81 to 2.99, and a Piotroski F-Score of 4 of 9, in the average band of 3 to 7.

    Altman Z-Score2.29
    Altman Z ZoneGrey
    Piotroski F-Score4 of 9
    Piotroski StrengthAverage

    Income Statement

    Revenue of $325.38M over the last 12 months is up 8.20% from the 12 months before.

    Revenue$325.38M
    Revenue Growth (YoY)+8.20%
    Gross Profit$181.07M
    Operating Income-$36.57M
    Pretax Income-$32.76M
    Net Income-$32.94M
    EBITDA-$9.94M
    EBIT-$32.38M
    Reported EPS (TTM)-$0.24

    Trailing 12 months through Aug 31, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 67.77% of the $241.93M in total assets.

    Cash and Equivalents$33.97M
    Total Debt$0
    Net Cash$33.97M
    Net Cash Per Share$0.81
    Working Capital$83.31M
    Shareholder Equity$163.96M
    Book Value Per Share$3.90
    Tangible Book Value$102.07M
    Tangible Book Per Share$2.43
    Total Assets$241.93M
    Total Liabilities$77.97M

    Balance sheet as of Aug 31, 2026.

    Full balance sheet

    Cash Flow

    After $8.37M of capital spending, operating cash flow left -$4.70M of free cash flow.

    Operating Cash Flow$3.67M
    Capital Expenditures$8.37M
    Free Cash Flow-$4.70M
    FCF Per Share-$0.11
    Depreciation and Amortization$22.43M

    Trailing 12 months through Aug 31, 2026.

    Full cash flow statement

    Margins

    The operating margin is -11.24%, against a 5-year average of -22.71%.

    Gross Margin55.65%
    Operating Margin-11.24%
    Pretax Margin-10.07%
    Net Margin-10.12%
    EBITDA Margin-3.06%
    EBIT Margin-9.95%
    FCF Margin-1.44%
    Gross Margin (5Y Average)52.66%
    Operating Margin (5Y Average)-22.71%
    Net Margin (5Y Average)-21.53%

    Growth

    Revenue fell 1.86% a year over 3 years.

    Revenue Growth (3Y CAGR)-1.86%
    Revenue Growth (5Y CAGR)+1.93%
    FCF Growth (5Y CAGR)-51.49%

    Revenue and profit by year

    Dividends and Yields

    ANGO does not pay a dividend. Its free cash flow yield is -0.97%.

    FCF Yield-0.97%
    Buyback Yield0.12%
    Shareholder Yield0.12%

    Peer Position

    Against 11 similar companies, ANGO has the 10th highest P/S.

    P/S Ratio1.5x vs 3.4x median
    Revenue Growth (Trailing 4 Quarters, YoY)+8.20% vs +7.29% median

    Competitors compared

    Analyst Forecast

    Consensus estimates put revenue growth at 5.28% a year over the next 2 fiscal years.

    Revenue Growth Forecast (2Y CAGR)+5.28%

    Analyst estimates by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    GNG Valuation

    GNG viewFairly valued

    GNG fair value is part of GNG Pro. See plans

    Frequently Asked Questions About ANGO

    What is ANGO's market cap?

    AngioDynamics has a market cap of $495.40M. Its enterprise value, which adds debt and subtracts cash, is $461.43M.

    How many shares of ANGO are outstanding?

    AngioDynamics has 42.02M shares outstanding. The count is up 2.06% from a year earlier.

    Does ANGO pay a dividend?

    No. AngioDynamics does not pay a dividend.

    How much debt does ANGO have?

    AngioDynamics has $0 of total debt and $33.97M of cash and equivalents, a net cash position of $33.97M.